Publications by authors named "Chung Jen Yu"

Claim this Profile
P
Prenatal diagnosis of Simpson-Golabi-Behmel syndrome type 1 with an 814 kb Xq26.2 deletion with the initial presentation of a thick nuchal fold.
Hsiu-Huei Peng, Chung Jen Yu, Yi Chi Chen, Chin-Chieh Hsu, Shuenn-Dyh Chang

Taiwan J Obstet Gynecol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.
Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang

Clin Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.
Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang

Clin Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.
Chih-Yi Lin, Chung-Jen Yu, Chia-I Shen, Chun-Yu Liu, Ta-Chung Chao

Med Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.
Celine Pallaud, Martin Reck, Erzsebet Juhasz, Barna Szima, Chung-Jen Yu

Lung Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
Pao-Yu Chen, Yu-Chung Chuang, Jann-Tay Wang, Wang-Huei Sheng, Chung-Jen Yu

J Microbiol Immunol Infect· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial.
James Chih-Hsin Yang, Jin-Yuan Shih, Wu-Chou Su, Te-Chun Hsia, Chun-Ming Tsai, Chung-Jen Yu, Xiuyu Julie Cong

Lancet Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of dhaD and dhaK abolishes by-product accumulation during 1,3-propanediol production in Klebsiella pneumoniae.
Yu-Tze Horng, Kai-Chih Chang, Ta-Chung Chou, Chung-Jen Yu, Chih-Ching Chien, Yu-Hong Wei

J Ind Microbiol Biotechnol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis